CAXTON ASSOCIATES LP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 209 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAXTON ASSOCIATES LP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$895,000
+225.5%
53,222
+130.2%
0.08%
+52.9%
Q1 2020$275,000
+5.0%
23,120
+6.7%
0.05%
+41.7%
Q4 2019$262,000
+31.7%
21,673
+110.4%
0.04%
+414.3%
Q3 2017$199,00010,3000.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders